Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DIEGO T TORRES II

Allopathic & Osteopathic Physicians Family Medicine

NPI
1821093105
CMS profile
415107
Location
ORMOND BEACH, FL

General Payments · PY2018–2024

$3,225.66

  • Reported across 176 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$942.32

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $942.32 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $246.06 9
Renalytix AI, Inc. $148.04 3
Novo Nordisk AS $123.69 7
ABIOMED $99.28 3
PFIZER INC. $90.54 4
ABBVIE INC. $88.58 2
ATRICURE, INC. $48.74 2
Amgen Inc. $36.91 2
Merz Pharmaceuticals, LLC $25.56 1
Abbott Laboratories $18.21 1
GlaxoSmithKline, LLC. $16.71 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $277.13 18
PY2019 $168.05 12
PY2020 $493.36 36
PY2021 $560.53 32
PY2022 $426.75 24
PY2023 $357.52 19
PY2024 $942.32 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $18.21 01/11/2024 Food and Beverage Undisputed 01/23/2026 1125288940 CMS
ABBVIE INC. $17.13 02/29/2024 Food and Beverage Undisputed 01/23/2026 1106234302 CMS
ABBVIE INC. $71.45 10/01/2024 Food and Beverage Undisputed 01/23/2026 1106234304 CMS
ABIOMED $31.78 08/07/2024 Food and Beverage Undisputed 01/23/2026 1142307008 CMS
ABIOMED $40.38 09/25/2024 Food and Beverage Undisputed 01/23/2026 1142307012 CMS
ABIOMED $27.12 10/07/2024 Food and Beverage Undisputed 01/23/2026 1142307010 CMS
Amgen Inc. $16.34 01/11/2024 Food and Beverage Undisputed 01/23/2026 1117400478 CMS
Amgen Inc. $20.57 10/03/2024 Food and Beverage Undisputed 01/23/2026 1117400480 CMS
AstraZeneca Pharmaceuticals LP $56.65 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104313432 CMS
AstraZeneca Pharmaceuticals LP $59.81 02/13/2024 Food and Beverage Undisputed 01/23/2026 1105451604 CMS
AstraZeneca Pharmaceuticals LP $23.74 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104650817 CMS
AstraZeneca Pharmaceuticals LP $19.15 05/09/2024 Food and Beverage Undisputed 01/23/2026 1104627874 CMS
AstraZeneca Pharmaceuticals LP $16.99 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105862590 CMS
AstraZeneca Pharmaceuticals LP $14.90 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104494566 CMS
AstraZeneca Pharmaceuticals LP $13.73 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104506852 CMS
AstraZeneca Pharmaceuticals LP $21.88 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105555778 CMS
AstraZeneca Pharmaceuticals LP $19.21 09/26/2024 Food and Beverage Undisputed 01/23/2026 1105218595 CMS
ATRICURE, INC. $27.73 09/10/2024 Food and Beverage Undisputed 01/23/2026 1132886331 CMS
ATRICURE, INC. $21.01 09/10/2024 Food and Beverage Undisputed 01/23/2026 1132886439 CMS
GlaxoSmithKline, LLC. $16.71 03/07/2024 Food and Beverage Undisputed 01/23/2026 1115988900 CMS
Merz Pharmaceuticals, LLC $25.56 09/30/2024 Food and Beverage Undisputed 01/23/2026 1137948662 CMS
Novo Nordisk Inc $15.39 02/21/2024 Food and Beverage Undisputed 01/23/2026 1097811567 CMS
Novo Nordisk Inc $20.18 04/11/2024 Food and Beverage Undisputed 01/23/2026 1096571718 CMS
Novo Nordisk Inc $16.19 05/30/2024 Food and Beverage Undisputed 01/23/2026 1096934733 CMS
Novo Nordisk Inc $24.20 07/25/2024 Food and Beverage Undisputed 01/23/2026 1097126495 CMS
Novo Nordisk Inc $14.55 08/15/2024 Food and Beverage Undisputed 01/23/2026 1096821537 CMS
Novo Nordisk Inc $19.42 08/30/2024 Food and Beverage Undisputed 01/23/2026 1096895413 CMS
Novo Nordisk Inc $13.76 09/12/2024 Food and Beverage Undisputed 01/23/2026 1097435096 CMS
PFIZER INC. $18.54 02/01/2024 Food and Beverage Undisputed 01/23/2026 1130960454 CMS
PFIZER INC. $21.57 03/28/2024 Food and Beverage Undisputed 01/23/2026 1131217766 CMS
PFIZER INC. $25.70 05/02/2024 Food and Beverage Undisputed 01/23/2026 1131495589 CMS
PFIZER INC. $24.73 07/11/2024 Food and Beverage Undisputed 01/23/2026 1131779108 CMS
Renalytix AI, Inc. $24.72 02/08/2024 Food and Beverage Undisputed 01/23/2026 1116760188 CMS
Renalytix AI, Inc. $21.35 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116760190 CMS
Renalytix AI, Inc. $101.97 07/10/2024 Food and Beverage Undisputed 01/23/2026 1116760192 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.